What is an Investigational New Drug (IND) Application?
Before a drug can be tested in humans, the pharmaceutical company must submit an Investigational New Drug (IND) application to the FDA. This application includes preclinical data, a proposed clinical trial plan, and information about the manufacturing process. The FDA reviews the IND to ensure that the proposed studies do not place human subjects at unreasonable risk.
